![]() |
![]() |
![]() |
|||||||||||||||||
![]() |
|
![]() |
|||||||||||||||||
![]() |
|
![]() |
|||||||||||||||||
![]() |
FDA Issues Warning | ||||||||||||||||||
|
BS'D About Test Strips That Can Give False
The U.S. Food and Drug Administration has issued a
warning against the use of GDH-PQQ blood glucose test strips by people with
diabetes who are taking medications that contain non-glucose sugars. [Note:
GDH-PQQ is the abbreviation of "glucose dehydrogenase pyrroloquinoline quinone,"
a chemical that reacts with the non-glucose sugars maltose, galactose, and
xylose, which are contained in some therapeutic
products.] Because the strips can mistake non-glucose sugars for
glucose, they can give an inaccurately high BG reading that could lead to an
insulin overdose. The FDA warning is based on 13 deaths between 1997 and
2009 that were reported in healthcare facilities where patients were using the
test strips. People with diabetes who are at highest risk are those undergoing
dialysis or recovering from recent surgery. According to the FDA alert, "Non-glucose sugars contained
in some therapeutic products, such as peritoneal dialysis solutions and certain
immunoglobulins, can falsely elevate glucose results, which may prompt excessive
insulin administration. These therapeutic products, which are labeled to
indicate that they may interfere with this particular glucose monitoring
technology, are mostly used in patients with serious medical conditions,
including kidney failure and moderate to severe rheumatoid
arthritis." List of GDH-PQQ Glucose Test
Strips The FDA noted that the following test strips and their
associated meters use GDH-PQQ methodology as of August
2009. Roche
Diagnostics
Abbott Diabetes
Care
Home
Diagnostics
Smiths
Medical
Insulet
The FDA notes that test strips may be
distributed under multiple trade names. Because manufacturers of GDH-PQQ test
strips currently on the market may subsequently change to non-GDH-PQQ
methodology, the FDA recommends that healthcare providers and patients refer to
the labeling on their test devices or consult with test strip manufacturers to
confirm the type of BG measuring methodology they use. The FDA warning and the agency's patient advice are available
online. Manufacturer Responses Glucose test strip manufacturers have begun to respond to
the FDA warning. Bayer Diabetes Care said, "Since 2006, Bayer Diabetes
Care has not distributed test strips that use GDH-PQQ (glucose dehydrogenase
pyrroloquinoline quinone) glucose monitoring technology for its blood glucose meters." Arkray stated "The GLUCOCARD 01 and Assure
families of products use a glucose-specific enzyme and can, therefore,
distinguish between glucose and other sugars. In light of the FDA's
announcement, ARKRAY will upgrade any consumer concerned about their GDH system
to a product from the GLUCOCARD 01 family at no
charge."
|
||||||||||||||||||
![]() |
![]() |
||||||||||||||||||
![]() |
![]() |
![]() |
|||||||||||||||||
![]() |
![]() |
![]() |